Given the importance of identifying signaling pathways that induce beige fat and alleviate obesity-related dysfunction in adipose tissue, our research findings suggest that hesperetin and activation of the intracellular signaling of ADGRA3 could serve as a promising and innovative therapeutic approach. Here, ADGRA3 is linked to obesity disorder.